Skip links
investdoor

Not very opportunity is meant to be public. Ours are built to be discovered.

CHIL offers investors access to curated investment opportunities across both company and project levels.

CHIL selectively opens company-level participation, project-based opportunities, and platform-focused collaborations. Each opportunity is structured to ensure long-term relevance, scalability, and responsible expansion.

Why Now?

This is not an early-stage concept, but a deliberate phase of expansion shaped by readiness, clarity, and long-term strategic intent.

CHIL has reached a point where its platforms, capabilities, and global readiness align, making this a deliberate moment to engage, as global demand for accessible diagnostics continues to rise.

Why CHIL?

Built as a founder-led and self-funded organization, CHIL has reached a stage where scale, speed, and global reach can be accelerated through aligned capital. CHIL combines deep diagnostic expertise with proven R&D, manufacturing and commercialization capabilities. We do not pursue growth for its own sake, we build systems designed to endure.

Our experience clearly defines what can and cannot be built and, more importantly, what will truly create impact. We engage with a strong sense of ownership toward our partners and projects, protecting our partners from unnecessary investment while focusing on what is achievable. And even more exciting is that those who walk the path with us discover our further strengths and value unfolding over time.

What We Opened?

morcares™ Platform

morcares™ Platform

BCSS Initiative

A Select Cancer Diagnostics Platform

CHIL is opening a focused investment opportunity around a cancer diagnostics platform designed to address a clear and persistent gap in early access and screening. Developed through years of in-house research and validated through a disciplined, founder-led approach, this platform is now ready to move forward with aligned strategic partners.

Engagement is structured, selective, and purpose-driven, offering participation at the platform or project level for investors who share a long-term perspective on valuation, scalability, and responsible growth.

Details are intentionally shared through private dialogue only, ensuring alignment, discretion, and a shared vision from the outset. 

Mission-Aligned Programs

Mission-Aligned Programs

CHIL works with funds, foundations, and corporate investment arms seeking to advance healthcare, medical, and biotechnology initiatives through clearly defined projects. These collaborations may be built around CHIL’s existing platforms or shaped around partner-led concepts requiring technical development, production capability, or structured execution.

Whether the objective is public health impact, access-driven diagnostics, or mission-aligned medical solutions, we engage through focused project structures rather than broad disclosure. We align intent, scope, and execution to transform concepts into tangible, deployable outcomes.

Localized Production Enablement

Localized Production Enablement

We open our confidential expertise and capabilities to partners seeking to establish or support local production, enabling the development of diagnostic systems based on diverse testing methodologies. Through structured frameworks, we support scalable, regionally grounded manufacturing aligned with real-world needs.

Who is this for?

This is for a select group of funds, foundations, corporate partners, and individual investors aligned with disciplined, execution-led engagement in healthcare and biotechnology. Participation is shaped by strategic fit, practical feasibility, and long-term impact orientation.

CONTACT

How Do We Engaged?

If our approach aligns with your investment philosophy, we welcome a direct and confidential discussion.

Atatürk OSB, 10046. Sk. No:18, 35620
Çiğli /İzmir

Email: investdoor@chil.com.tr

Phone: +90 (532) 320 24 45

Investors Form
First
Last
Explore
Drag